Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition.


Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
01 2020
Historique:
received: 13 09 2019
revised: 17 10 2019
pubmed: 28 10 2019
medline: 9 2 2021
entrez: 25 10 2019
Statut: ppublish

Résumé

The bile acid (BA) composition in mice is substantially different from that in humans. Chenodeoxycholic acid (CDCA) is an end product in the human liver; however, mouse

Identifiants

pubmed: 31645370
pii: S0022-2275(20)30016-X
doi: 10.1194/jlr.RA119000395
pmc: PMC6939601
pii:
doi:

Substances chimiques

Bile Acids and Salts 0
Chenodeoxycholic Acid 0GEI24LG0J
Cytochrome P-450 Enzyme System 9035-51-2
cytochrome P-450 2C70, mouse EC 1.-
Steroid Hydroxylases EC 1.14.-
Aryl Hydrocarbon Hydroxylases EC 1.14.14.1
steroid hormone 7-alpha-hydroxylase EC 1.14.14.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-69

Informations de copyright

Copyright © 2020 Honda et al.

Références

Inflamm Bowel Dis. 2018 Apr 23;24(5):1035-1044
pubmed: 29688473
J Lipid Res. 2016 Dec;57(12):2130-2137
pubmed: 27638959
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3369-74
pubmed: 11248085
PLoS One. 2014 Apr 22;9(4):e93567
pubmed: 24755711
Hepatology. 1998 Oct;28(4):1088-94
pubmed: 9755247
Science. 2018 May 25;360(6391):
pubmed: 29798856
Biochem Pharmacol. 2012 Oct 15;84(8):1000-6
pubmed: 22820246
Biochim Biophys Acta. 2011 Mar;1809(3):157-65
pubmed: 21296199
J Biol Chem. 2003 Mar 14;278(11):9435-40
pubmed: 12524422
Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):55-67
pubmed: 23982684
J Biol Chem. 2001 Sep 14;276(37):34579-85
pubmed: 11454857
Biochim Biophys Acta. 2011 Aug;1812(8):842-50
pubmed: 21130162
Cell Metab. 2013 Feb 5;17(2):225-35
pubmed: 23395169
J Hepatol. 2017 Sep;67(3):619-631
pubmed: 28712691
Science. 1999 May 21;284(5418):1362-5
pubmed: 10334992
J Biol Chem. 2013 May 10;288(19):13850-62
pubmed: 23546875
J Appl Toxicol. 2018 Oct;38(10):1323-1335
pubmed: 29785833
Hepatology. 2019 May;69(5):2241-2257
pubmed: 30372785
J Biol Chem. 2000 Jul 21;275(29):21805-8
pubmed: 10823815
J Biol Chem. 2006 Sep 22;281(38):27816-26
pubmed: 16857673
Am J Physiol Gastrointest Liver Physiol. 2005 Apr;288(4):G685-95
pubmed: 15550563
Oncotarget. 2016 Dec 20;7(51):83951-83963
pubmed: 27924062
Best Pract Res Clin Gastroenterol. 2018 Jun - Aug;34-35:3-9
pubmed: 30343708
Hepatology. 2007 Feb;45(2):422-32
pubmed: 17256725
Nat Med. 2018 Dec;24(12):1919-1929
pubmed: 30397356
Drug Metab Dispos. 2009 May;37(5):1035-45
pubmed: 19196849
J Lipid Res. 2007 May;48(5):1212-20
pubmed: 17272831
J Steroid Biochem Mol Biol. 2010 Aug;121(3-5):556-64
pubmed: 20302936
Cell Metab. 2005 Oct;2(4):217-25
pubmed: 16213224
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):895-911
pubmed: 29782919
J Biol Chem. 2004 Nov 19;279(47):49517-22
pubmed: 15358766
J Med Chem. 2014 Dec 26;57(24):10343-54
pubmed: 25411721
J Biol Chem. 2002 Sep 13;277(37):34036-41
pubmed: 12119285
Nat Microbiol. 2019 Mar;4(3):492-503
pubmed: 30643240
Hepatology. 2006 Jun;43(6):1202-10
pubmed: 16729332
Drug Metab Dispos. 2015 Mar;43(3):335-43
pubmed: 25527709
J Biol Chem. 2019 May 31;294(22):8732-8744
pubmed: 30996006
J Lipid Res. 1999 Aug;40(8):1520-8
pubmed: 10428990
J Biol Chem. 2000 Sep 15;275(37):28947-53
pubmed: 10867000
Hepatology. 1984 Jul-Aug;4(4):661-6
pubmed: 6745854
Science. 1981 Dec 11;214(4526):1244-6
pubmed: 6272397
J Clin Invest. 2015 Jan;125(1):386-402
pubmed: 25500885
J Lipid Res. 2019 Sep 10;:null
pubmed: 31506275
Cell. 2019 Feb 21;176(5):1098-1112.e18
pubmed: 30794774
Am J Physiol Gastrointest Liver Physiol. 2005 Jan;288(1):G74-84
pubmed: 15331348
J Biol Chem. 2001 Aug 3;276(31):28857-65
pubmed: 11387316
Gastroenterology. 2001 Jul;121(1):140-7
pubmed: 11438503
Hum Genomics. 2005 Sep;2(3):196-201
pubmed: 16197738
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3375-80
pubmed: 11248086
Drug Metab Dispos. 2017 Jul;45(7):807-816
pubmed: 28450579
Hepatology. 2013 May;57(5):1931-41
pubmed: 22911624
J Lipid Res. 2016 Dec;57(12):2097-2098
pubmed: 27777318
Hepatology. 1994 Apr;19(4):1007-12
pubmed: 8138240
Nat Rev Microbiol. 2014 Oct;12(10):661-72
pubmed: 25198138
J Lipid Res. 1989 May;30(5):719-30
pubmed: 2760545
Immunity. 2016 Oct 18;45(4):802-816
pubmed: 27692610
Exp Anim. 2017 Oct 30;66(4):437-445
pubmed: 28717054
Science. 1999 May 21;284(5418):1365-8
pubmed: 10334993
J Lipid Res. 1988 Feb;29(2):136-43
pubmed: 3367083
Arch Biochem Biophys. 1998 Mar 1;351(1):60-5
pubmed: 9500848
Drug Metab Dispos. 2006 May;34(5):756-64
pubmed: 16455805
J Biol Chem. 1981 Aug 25;256(16):8658-62
pubmed: 7263676
Hepatology. 2005 Jan;41(1):168-76
pubmed: 15619241
Front Pharmacol. 2016 Nov 25;7:456
pubmed: 27932985
Mol Pharmacol. 2012 Dec;82(6):1022-9
pubmed: 22918969
Hepatology. 2004 Jul;40(1):149-56
pubmed: 15239098
Hepatology. 2006 Sep;44(3):602-11
pubmed: 16941710
J Lipid Res. 1978 Aug;19(6):723-8
pubmed: 690512
J Lipid Res. 2001 Feb;42(2):291-300
pubmed: 11181760
PLoS One. 2012;7(3):e32551
pubmed: 22403674
J Lipid Res. 2000 Apr;41(4):514-20
pubmed: 10744771
Nature. 2013 Jul 4;499(7456):97-101
pubmed: 23803760
J Lipid Res. 2010 Nov;51(11):3230-42
pubmed: 20671298
Adv Drug Deliv Rev. 2010 Oct 30;62(13):1238-49
pubmed: 20727377
Hepatology. 2013 Apr;57(4):1509-17
pubmed: 23184615
Toxicol Sci. 2011 Dec;124(2):261-77
pubmed: 21920951

Auteurs

Akira Honda (A)

Joint Research Center, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan; Department of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan. Electronic address: akirahonda-gi@umin.ac.jp.

Teruo Miyazaki (T)

Joint Research Center, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Junichi Iwamoto (J)

Department of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Takeshi Hirayama (T)

Department of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Yukio Morishita (Y)

Diagnostic Pathology Division, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Tadakuni Monma (T)

Department of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Hajime Ueda (H)

Department of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Seiya Mizuno (S)

Laboratory Animal Resource Center, University of Tsukuba, Ibaraki, Japan.

Fumihiro Sugiyama (F)

Laboratory Animal Resource Center, University of Tsukuba, Ibaraki, Japan.

Satoru Takahashi (S)

Laboratory Animal Resource Center, University of Tsukuba, Ibaraki, Japan.

Tadashi Ikegami (T)

Department of Gastroenterology and Hepatology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH